首页> 外文期刊>Central European Journal of Urology: The Polish Journal of Urology >Can we consider temporary, preoperative active observation in patients with kidney tumors up to 3 cm in order to decrease the number of patients over-treated with NSS – nephron sparing surgery?
【24h】

Can we consider temporary, preoperative active observation in patients with kidney tumors up to 3 cm in order to decrease the number of patients over-treated with NSS – nephron sparing surgery?

机译:我们是否可以考虑对3 cm以下的肾脏肿瘤患者进行临时的术前主动观察,以减少接受NSS肾保留手术的过度治疗的患者人数?

获取原文
           

摘要

Introduction. The increasing number of benign andnon-cancerous tumors has resulted in the common useof NSS for the treatment of pT1 tumors. However, thiskind of treatment did not reduce the number of unnecessaryoperations.Material and methods. Two-hundred nineteen patientswith pT1 tumors treated with NSS were analyzed retrospectively.The mean time of observation was 77.9months. The patients were divided into groups dependingon tumor size and the degree of cellular differentiationof the tumor – DCTD (according to Fuhrman).Results. Statistical analysis revealed that an increasein tumor diameter accompanied a decrease in the percentageof patients with tumors staged pT1 as well asthose graded G1 and G0 (according to Fuhrmann). Meansurvival time also decreases. While the percentage oftumors graded G3, those staged pT3, unconventionalvarieties of renal cell carcinoma (RCC), local recurrence,as well as renal insufficiency all increase together withincreases in tumor diameter.Conclusions. In patients with tumors up to 3 cm, therisk of surgical overtreatment increases. In patientswith pT1 increases: the risk of unconventional varietiesof RCC, cancerous progression, and death along withthe increase in the size of the tumor and DCTD. Alongwith the size of pT1 tumors, a decrease in the numberof benign and non-cancerous tumors as well as5-years survival after NSS is observed. The dynamics ofcancerous changes in the tumors up to 2 cm is similarto the dynamics observed in the tumors up to 3 cm,whereas those of 4 cm act similarly as the tumors of 5cm diameter
机译:介绍。良性和非癌性肿瘤数量的增加导致NSS通常用于治疗pT1肿瘤。但是,这种治疗方法并没有减少不必要的手术次数。材料和方法。回顾性分析了299例NSS治疗的pT1肿瘤患者。平均观察时间为77.9个月。根据肿瘤大小和肿瘤的细胞分化程度将其分为两组-DCTD(根据Fuhrman)。统计分析表明,肿瘤直径的增加伴随着分期为PT1以及分级为G1和G0的肿瘤患者百分比的减少(根据Fuhrmann)。平均生存时间也减少了。分级为G3的肿瘤的百分比,分级为pT3的肿瘤的百分比,肾细胞癌(RCC)的非常规变异,局部复发以及肾功能不全都在肿瘤直径的增加内一起增加。在肿瘤长至3 cm的患者中,手术过度治疗的风险增加。 pT1患者增加:RCC异常变种,癌变进展和死亡的风险以及肿瘤和DCTD的增加。随着pT1肿瘤的大小,良性和非癌性肿瘤的数量减少,NSS后的5年生存期也被观察到。长达2 cm的肿瘤的癌变动力学与长达3 cm的肿瘤的动力学相似,而4 cm的肿瘤与直径5 cm的肿瘤的行为相似

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号